Sort
82,697 grants matching “vaccine development”
CANCER CENTER SUPPORT GRANT
$2,547,570Gerold Bepler · Wayne State University · P30 · FY2012 · CA
Epigenomic analysis of primary immune cells from young and old animals
$2,546,202Myong-Hee Sung · National Institute On Aging · ZIA · FY2023 · AG
COMBINATION IMMUNIZATION AS AN APPROACH TO AIDS VACCINES
$2,545,773University Of Washington · P01 · FY2001 · AI
Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Inf
$2,545,494Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr · U19 · FY2014 · AI
Center for Viral Systems Biology (CViSB)
$2,544,897Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2024 · AI
Protective immunity following dengue virus natural infections and vaccination
$2,544,113Eva Harris · University Of California Berkeley · P01 · FY2021 · AI
ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM
$2,543,973Carlos A Sariol · University Of Puerto Rico Med Sciences · U24 · FY2012 · OD
Pre-clinical Vaccine Development for Respiratory Viruses
$2,543,625John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Advanced Development of Vaccines for Influenza
$2,543,566Uwe Staerz · Greffex, Inc. · N01 · FY2021 · AI
HPV Vaccine Trial
$2,542,862Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Novel Strategy to Induce Islet Protective Regulatory T Cells and Prevent Diabetes
$2,542,500Brian D Brown · Icahn School Of Medicine At Mount Sinai · DP2 · FY2008 · DK
Experimental Therapy for Brain Tumors
$2,542,342John H Sampson · Duke University · P01 · FY2021 · CA
NIAID Preclinical Development Support
$2,542,325Fred Mack · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
BSL-4 Evaluation Core (Core B)
$2,542,134Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2021 · AI
The Ohio State University AIDS Clinical Trials Unit
$2,542,078Susan L Koletar · Ohio State University · U01 · FY2008 · AI
Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development
$2,542,064Michael Gale · University Of Washington · N01 · FY2022 · AI
CANOE Partnership: Cancer Awareness, Navigation, Outreach, and Equitable Indigenous Health Outcomes
$2,541,510Lonnie A. Nelson · Fred Hutchinson Cancer Center · U19 · FY2025 · MD
NIDCD Core for Clinical Research and Care
$2,540,955Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2021 · DC
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,540,338Norman L Letvin · Beth Israel Deaconess Medical Center · N01 · FY2011 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$2,540,071Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2016 · AI
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
$2,539,719Wistar Institute · P30 · FY2004 · CA
Aging Intervention Studies
$2,539,532Julie Mattison · National Institute On Aging · ZIA · FY2022 · AG
Spore in Head and Neck Cancer
$2,539,302David Sidransky · Johns Hopkins University · P50 · FY2014 · DE
Protective immunity following dengue virus natural infections and vaccination
$2,539,162Eva Harris · University Of California Berkeley · P01 · FY2022 · AI
Core C - The University of Texas Medical Branch at Galveston
$2,538,747Thomas William Geisbert · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2023 · AI